Steering Board

Equally representing the sites of Munich, Münster and the Rhine-Main Neuroscience Network (rmn2), the role of the Steering Board is to – amongst other things – coordinate the needs of the individual research groups; examine membership applications; and present project and funding requests to the DFG on behalf of the CRC.

 

Prof. Dr. Heinz Wiendl Univ.-Prof. Prof. h.c. Dr. med. Heinz Wiendl (Münster), Spokesperson
Department für Neurologie – Klinik für Allgemeine Neurologie
Universitätsklinikum der Westfälische Wilhelms-Universität Münster
E-Mail: heinz.wiendl@ukmuenster.de

 

 

 

Prof. Dr. Frauke ZippUniv-Prof. Dr. med. Frauke Zipp (rmn2), Co-Spokesperson
Klinik und Poliklinik für Neurologie
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: frauke.zipp@unimedizin-mainz.de

 

 

 

Prof. Martin Kerschensteiner width=Prof. Dr. Martin Kerschensteiner, Secretary
Institut für klinische Neuroimmunologie
Ludwig-Maximilians-Universität München
E-Mail: martin.kerschensteiner@med.uni-muenchen.de

 

 

 

 

Prof. Dr. Thomas Korn Prof. Dr. Thomas Korn
Neurologische Klinik und Poliklinik
Klinikum Rechts der Isar
Technische Universität München
E-Mail: thomas.korn@tum.de

 

 

 

Prof. Lydia Sorokin, PhDUniv.-Prof. Dr. rer. nat. Lydia Sorokin
Institut für Physiologische Chemie und Pathobiochemie
Westfälische Wilhelms-Universität Münster
E-Mail: sorokin@uni-muenster.de

 

 

 

 

Prof. Ari Waisman, PhD Univ.-Prof. Dr. rer. nat. Ari Waisman, PhD
Institut für Molekulare Medizin,
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: waisman@uni-mainz.de

News

Tue, 17/10/2017
Three new CRC associates
Muenster / Mainz / Munich. The CRC is proud to welcome three scientists as new associates: Muthuraman Muthuraman (Mainz), Anneli Peters (LMU) and Gerd Meyer zu Hörste (Münster). All three are reputable neuroimmunologists, who add their in-depth knowledge of techniques and concepts to the existing team. Dr. Muthuraman Muthuraman is head of the scientific working group […]...more
Tue, 12/09/2017
Genetically altered mice provide initial evidence that human gut bacteria can trigger multiple sclerosis
Munich. (LMU)  Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system. There are many indications that MS is an autoimmune disease in which immune cells “accidentally” attack the brain and spinal cord. However, as with other autoimmune diseases, the actual triggers of the autoimmune reaction are still unknown. A new […]...more
Sun, 10/09/2017
SFB researcher acquired Hertie foundation funding
Munich. SFB CRC 128 researcher Dr. Klaus Lehmann-Horn, Department of Neurology, has acquired 396.000€ of funding as part of the framework „MyLab“, which is sponsored by the Hertie foundation. The duration of the project „Antigen-driven affinity maturation of B lymphocytes in meningeal ectopic lymphoid tissue in a model of Multiple Sclerosis“ will be 5 years, […]...more